![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.50 | 2.52% | 61.00 | 57.00 | 65.00 | 61.00 | 59.50 | 59.50 | 12,246 | 14:00:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investment Advice | 149k | -7.14M | -0.1082 | -5.64 | 39.26M |
TIDMCEL TIDMLLOY RNS Number : 9425Z Celsis International PLC 30 September 2009 +--------------------------------------------+ | | +--------------------------------------------+ | | +--------------------------------------------+ +----------------------------------------------------------------------------------------+ | TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES | +----------------------------------------------------------------------------------------+ +-------------------------------------------+-----------------------------------+ | 1. Identity of the issuer or the | Celsis International plc | | underlying issuer of existing shares to | | | which voting rights are attached: | | +-------------------------------------------+-----------------------------------+ +-------------------+---------------------------------------------------+--------+ | 2 Reason for the notification (please tick the appropriate box or boxes): | +--------------------------------------------------------------------------------+ | An acquisition or disposal of voting rights | | +-----------------------------------------------------------------------+--------+ | An acquisition or disposal of qualifying financial instruments which | | | may result in the acquisition of shares already issued to which | | | voting rights are attached | | +-----------------------------------------------------------------------+--------+ | An acquisition or disposal of instruments with similar economic | | | effect to qualifying financial instruments | | +-----------------------------------------------------------------------+--------+ | An event changing the breakdown of voting rights | | +-----------------------------------------------------------------------+--------+ | Other (please | | X | | specify): | | | +-------------------+---------------------------------------------------+--------+ +-------------------------------------------+-----------------------------------+ | 3. Full name of person(s) subject to | Lloyds Banking Group plc | | the notification obligation: | | | | | +-------------------------------------------+-----------------------------------+ | 4. Full name of shareholder(s) (if | See Section 9. | | different from 3.): | | | | | +-------------------------------------------+-----------------------------------+ | 5. Date of the transaction and date | 25 September 2009 | | on which the threshold is crossed | | | or reached: | | | | | +-------------------------------------------+-----------------------------------+ | 6. Date on which issuer notified: | 29 September 2009 | | | | +-------------------------------------------+-----------------------------------+ | 7. Threshold(s) that is/are crossed | Direct/Indirect decrease to below | | or reached: | 6% | | | | +-------------------------------------------+-----------------------------------+ +----------------+----------------+------------+----------------+----------+------------+----------+----------+ | 8. Notified details: | +-------------------------------------------------------------------------------------------------------------+ | A: Voting rights attached to shares | | | +-------------------------------------------------------------------------------------------------------------+ | Class/type of | Situation previous | Resulting situation after the triggering transaction | | shares | to the triggering | | | if possible | transaction | | | using | | | | the ISIN CODE | | | + +-----------------------------+--------------------------------------------------------------+ | | Number | Number | Number | Number of voting | % of voting rights | | | of | of | of | rights | | | | Shares | Voting | shares | | | | | | Rights | | | | + + + +----------------+-----------------------+---------------------+ | | | | Direct | Direct | Indirect | Direct | Indirect | +----------------+----------------+------------+----------------+----------+------------+----------+----------+ | Ord 5p Shares | 2,398,255 | 2,398,255 | 41,536 | 41,536 | 1,195,521 | 0.190% | 5.461% | +----------------+ + + + + + + + | GB00B0CDF69 | | | | | | | | +----------------+----------------+------------+----------------+----------+------------+----------+----------+ +---------------------+------------+--------------------+---------------------+----------------+ | B: Qualifying Financial Instruments | +----------------------------------------------------------------------------------------------+ | Resulting situation after the triggering transaction | | | +----------------------------------------------------------------------------------------------+ | Type of financial | Expiration | Exercise/ | Number of voting | % of voting | | instrument | date | Conversion | rights that may be | rights | | | | Period | acquired if the | | | | | | instrument is | | | | | | exercised/ | | | | | | converted. | | | | | | | | +---------------------+------------+--------------------+---------------------+----------------+ | | | | | | +---------------------+------------+--------------------+---------------------+----------------+ +---------------+----------+------------+------------+----------------+---------------+---------+ | C: Financial Instruments with similar economic effect to Qualifying Financial | | Instruments | +-----------------------------------------------------------------------------------------------+ | Resulting situation after the triggering transaction | | | +-----------------------------------------------------------------------------------------------+ | Type of | Exercise | Expiration | Exercise/ | Number of | % of voting | | financial | | | Conversion | voting | rights | | instrument | price | date | | rights | | | | | | period | instrument | | | | | | | refers to | | +---------------+----------+------------+------------+----------------+-------------------------+ | | | | | | Nominal | Delta | | | | | | | | | + + + + + +---------------+---------+ | | | | | | | | +---------------+----------+------------+------------+----------------+---------------+---------+ +-------------------------------------------+-----------------------------------+ | Total (A+B+C) | | | +-------------------------------------------------------------------------------+ | Number of voting rights | Percentage of voting rights | +-------------------------------------------+-----------------------------------+ | 1,237,057 | 5.650% | +-------------------------------------------+-----------------------------------+ +----------------------------------------------------------------------------------------+ | 9. Chain of controlled undertakings through which the voting rights and/or the | | financial instruments are effectively held, if applicable: | +----------------------------------------------------------------------------------------+ | 1,225,123 Shares (5.596%) are under the control of Insight Investment Management | | (Global) Limited, a wholly owned subsidiary of Insight Investment Management Limited, | | a wholly owned subsidiary of HBOS Insurance & Investment Group Limited, a wholly owned | | subsidiary of HBOS plc, a wholly owned subsidiary of Lloyds Banking Group plc | | (Direct/Indirect). | +----------------------------------------------------------------------------------------+ +-------------------------------------------+-----------------------------------+ | Proxy Voting: | | | +-------------------------------------------------------------------------------+ | 10. Name of the proxy holder: | N/A | | | | +-------------------------------------------+-----------------------------------+ | 11. Number of voting rights proxy holder | N/A | | will cease to hold: | | | | | +-------------------------------------------+-----------------------------------+ | 12. Date on which proxy holder will cease | N/A | | to hold voting rights: | | | | | +-------------------------------------------+-----------------------------------+ +-------------------------------------------+-----------------------------------+ | 13. Additional information: | Notification using the Total | | | Voting Rights figure of | | | 21,892,528 | +-------------------------------------------+-----------------------------------+ | 14. Contact name: | Kenny Melville | | | | +-------------------------------------------+-----------------------------------+ | 15. Contact telephone number: | 0131 243 8671 | | | | +-------------------------------------------+-----------------------------------+ This information is provided by RNS The company news service from the London Stock Exchange END HOLUROKRKURKORR
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions